Risk factors for bladder cancer

Tumori

Volumn 93, Issue 1, 2007, Pages 4-12

  Janković, Slavenka ^a,c   Radosavljević, Vladan ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute of Preventive Medicine Zemun   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Bladder cancer; Epidemiology; Occupational exposure; Risk factors; Smoking

Indexed keywords

3 CHLORO 4 DICHLOROMETHYL 5 HYDROXY 2(5H) FURANONE; 4 BIPHENYLAMINE; ACETIC ACID; ACETYLSALICYLIC ACID; ACROLEIN; ACYLTRANSFERASE; AROMATIC AMINE; ARSENIC; ARYLAMINE ACETYLTRANSFERASE; ASPHALT; BENZIDINE; CYCLOPHOSPHAMIDE; DRINKING WATER; FURANONE DERIVATIVE; GLUTATHIONE TRANSFERASE M1; HAIR DYE; HETEROCYCLIC COMPOUND; LUBRICATING AGENT; NITRATE; NITROSO DERIVATIVE; OXICAM DERIVATIVE; PHENACETIN; PLASTIC; POLYCYCLIC AROMATIC HYDROCARBON; REACTIVE OXYGEN METABOLITE; RUBBER; TRIHALOMETHANE; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG EXPOSURE; ENDEMIC DISEASE; FLUID INTAKE; HEREDITY; HUMAN; INDUSTRIALIZATION; INFORMATION RETRIEVAL; MEDLINE; META ANALYSIS; OCCUPATIONAL EXPOSURE; RISK REDUCTION; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; WEGENER GRANULOMATOSIS;

EID: 33947723576     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160709300102     Document Type: Article

References (101)

1. Ferlay J, Bray F, Pisani P, Parkin DM: Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide. International Agency for research on Cancer. Cancer Base no. 5 version 2.0. IARC, Lyon, 2004 [cited 5th May 2006]. Available from: http://www-dep.iarc.fr
2. Kogevinas M, Trichopoulos D: Urinary bladder cancer. In: Textbook of Cancer Epidemiology, Adami HO, Hunter D, Trichopoulos D (Eds), pp 446-466, Oxford University Press, New York, 2002.
3. World Health Organization: Changing history. The world health report 2004. World Health Organization, Geneva, 2004.
4. Pashos CL, Botteman MF, Laskin BL, Redaelli A: Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract, 10: 311-322, 2002.
5. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 80: 827-841, 1999.
6. Silverman DT, Hartge P, Morrison AS, Devesa SS: Epidemiology of bladder cancer. Hematol Oncol Clin N Am, 6: 1-30, 1992.
7. National Cancer Institute: A Snapshot of Bladder Cancer [cited 5th May 2006]. Available from: http://planning.cancer.gov/disease/snapshots.shtml
8. McLellan RA, French CG, Bell DG: Trends in the incidence of bladder cancer in Nova Scotia: a twenty-year perspective. Can J Urol, 10: 1880-1884, 2003.
9. Hayne D, Arya M, Quinn MJ, Babb PJ, Beacock CJM, Patel HR: Current trends in bladder cancer in England and Wales. J Urol, 172: 1051-1055, 2004.
10. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C: Mechanisms of disease: the epidemiology of bladder cancer. Natl Clin Pract Urol, 3: 327-340, 2006.
11. Negri E, La Vecchia C: Epidemiology and prevention of bladder cancer. Eur J Cancer Prev, 10: 7-14, 2001.
12. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C: Cancer mortality in Europe, 1990-1994, and overview of trends from 1955 to 1994. Eur J Cancer, 35: 1477-1516, 1999.
13. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA: The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer, 89: 630-639, 2000.
14. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA: The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol, 21: 392-401, 2004.
15. Marcus PM, Hayes R, Vineis P, Garcia-Closas M, Caporaso N, Autrup H, Branch RA, Brockmöller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I, Rothman N: Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev, 9: 461-467, 2000.
16. Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-Audorff U, Jöckel KH, Donato F, Serra C, Wahrendorf J, Hours M, T'Mannetje A, Kogevinas M, Boffetta P: Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer, 86: 289-294, 2000.
17. Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, Jöckel KH, Lopez-Abente G, Tzonou A, Vineis P, Donato F, Hours M, Serra C, Bolm-Audorff U, Schill W, Kogevinas M, Boffetta P: The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control, 12: 411-417, 2001.
18. Pelucchi C, La Vecchia, Negri E, Dal Maso L, Franceschi S: Smoking and other risk factors for bladder cancer in women. Prev Med, 35: 114-120, 2002.
19. D'Avanzo B, La Vecchia C, Negri E, Decarli A, Benichou J: Attributable risks for bladder cancer in Northern Italy. Ann Epidemiol, 5: 427-431, 1995.
20. Siemiatycki J, Krewski D, Franco E, Kaiserman M: Associations between cigarette smoking and each of 21 types of cancer: a multi-site case-control study. Int J Epidemiol, 24: 504-514, 1995.
21. Zeegers MP, Goldbohm RA, van den Brandt PA: A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control, 13: 83-90, 2002.
22. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC: Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst, 93: 538-545, 2001.
23. Shapiro JA, Jacobs EJ, Thun MJ: Cigar smoking in men and risk of death from tobacco-related cancers. J Natl Cancer Inst, 92: 333-337, 2000.
24. Gaertner R, Trpeski L, Johnson KC; The Canadian Cancer Registries Epidemiology Research Group: A case-control study of occupational risk factors for bladder cancer in Canada. Cancer Causes Control, 15: 1007-1019, 2004.
25. International Agency for research on Cancer: Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol. 83, IARC, Lyon, 2004.
26. Vineis P, Simonato L: Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach. Arch Environ Health 46: 6-15, 1991.
27. Kogevinas M, T'Mannetje A, Cordier S, Ranft Ulrich, Gonzalez CA, Vineis P, Chang-Claude J, Lynge E, Wahrendorf J, Tzonou A, Jockel K-H, Serra C, Porru S, Hours M, Greiser E, Boffetta P: Occupation and bladder cancer among men in Europe. Cancer Causes Control, 14: 907-914, 2003.
28. Barone-Adesi F, Richiardi L, Merletti F: Population attributable risk for occupational cancer in Italy. Int J Occup Environ Health, 11: 23-31, 2005.
29. International Agency for Research on Cancer: Occupational exposures of hairdressers and barbers and personal use of hair colourants; some hair dyes, cosmetic colourants, industrial dyestuffs and aromatic amines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 57, IARC, Lyon, 1993.
30. La Vecchia C, Tavani A: Epidemiological evidence on hair dyes and the risk of cancer in humans. Eur J Cancer Prev, 4: 31-43, 1995.
31. Gago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK: Use of permanent hair dyes and bladder cancer risk. Int J Cancer, 91: 575-579, 2001.
32. Czene K, Tiikkaja S, Hemminki K: Cancer risks in hair-dressers: assessment of carcinogenicity of hair dyes and gels. Int J Cancer, 105: 108-112, 2003.
33. Zheng T, Cantor KP, Zhang Y, Lynch CF: Occupation and bladder cancer: a population-based, case-control study in Iowa. J Occup Environ Med, 44: 685-691, 2002.
34. Colt JS, Baris D, Stewart P, Schned AR, Heaney JA, Mott LA, Silverman D, Karagas M: Occupation and bladder cancer risk in a population-based case-control study in New Hampshire. Cancer Causes Control, 15: 759-769, 2004.
35. Silverman DT, Morrison AS, Devesa SS: Bladder cancer. In: Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni JF Jr (Eds), 2nd edition, pp 1156-1179, Oxford University Press, New York, 1996.
36. Bosetti C, Pira E, La Vecchia C: Bladder cancer risk in painters: a review of the epidemiological evidence, 1894-2004. Cancer Causes Control, 16: 997-1008, 2005.
37. Gaertner RRW, Theriault: Risk of bladder cancer in foundry workers: a meta-analysis. Occup Environ Med, 59: 655-663, 2002.
38. Zeegers MP, Swaen GM, Kant I, Goldbohm RA, van den Brandt PA: Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands. Occup Environ Med, 58: 590-596, 2001.
39. Yu MC, Skipper PL, Tannenbaum SR, Chan KK, Ross RK: Arylamine exposures and bladder cancer risk. Mutat Res, 506-507: 21-28, 2002.
40. Puntoni R, Ceppi M, Gennaro V, Ugolini D, Puntoni M, LaManna G, Casella C, Merlo D F: Occupational exposure to carbon black and risk of cancer. Cancer Causes Control, 15: 511-516, 2004.
41. Smailyte G, Kurtinaitis J, Andersen A: Mortality and cancer incidence among Lithuanian cement-producing workers. Occup Environ Med, 61: 529-534, 2004.
42. Ugnat AM, Luo W, Semenciw R, Mao Y; The Canadian Cancer Registries Epidemiology Research Group: Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces. Chronic Dis Can, 25: 7-15, 2004.
43. Takkouche B, Etminan M, Montes-Martinez A: Personal use of hair dyes and risk of cancer: a meta-analysis. JAMA, 293: 2516-2525, 2005.
44. MacDonald R: Providing clean water: Lessons from Bangladesh. BMJ, 322: 626-627, 2001.
45. Anawar HM, Akai J, Mostofa KMG, Safinllah S, Tareq SM: Arsenic poisoning in groundwater: Health risk and geochemical sources in Bangladesh. Environ Int, 27: 597-604, 2002.
46. British Geological Survey. The groundwater arsenic problem in Bangladesh (phase 2) [cited 8th June 2006]. Available from: http://www.bgs.ac.uk/arsenic
47. Chen Y, Ahsan H: Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health, 94: 741-744, 2004.
48. Schoen A, Beck B, Sharma R, Dubé E: Arsenic toxicity at low doses: epidemiological and mode of action considerations. Toxicol Appl Pharmacol, 198: 253-267, 2004.
49. Steinmaus C, Yuan Y, Bates MN, Smith AH: Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol, 158: 1193-1201, 2003.
50. Villanueva CM, Fernández F, Malats N, Grimalt JO, Kogevinas M: Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. J Epidemiol Community Health, 57: 166-173, 2003.
51. Chevrier C, Junod B, Cordier S: Does ozonation of drinking water reduce the risk of bladder cancer? Epidemiology, 15: 605-614, 2004.
52. Weyer PJ, Cerhan JR, Kross BC, Hallberg GR, Kantamneni J, Breuer G, Jones MP, Zheng W, Lynch CF: Municipal drinking water nitrate level and cancer risk in older women: the Iowa Women's Health Study. Epidemiology, 12: 327-338, 2001.
53. Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, Lynch CF, Porru S, Kogevinas M: Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer, 118: 2040-2047, 2006.
54. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GL, Willett WC, Giovanucci EL: Fluid intake and the risk of bladder cancer in men. N Engl J Med, 340: 1390-1397, 1999.
55. Radosavljević V: Fluid balance, diet and bladder cancer occurrence. Eur J Cancer Prev, 13: 151, 2004.
56. Radosavljević V, Janković S, Marinković J, Crossed D signokić M: Fluid intake and bladder cancer: A case-control study. Neoplasma, 50: 234-238, 2003.
57. International Agency for Research on Cancer: Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol 51, IARC, Lyon, 1991.
58. Tavani A, La Vecchia C: Coffee and cancer: a review of epidemiological studies, 1990-1999. Eur J Cancer Prev, 9: 241-256, 2000.
59. Djousse L, Schatzkin A, Chibnik LB, D'Agostino RB, Kreger BE, Ellison RC: Alcohol consumption and the risk of bladder cancer in the Framingham Heart Study. J Natl Cancer Inst, 96: 1397-1400, 2004.
60. Bianchi GD, Cerhan JR, Parker AS, Putnam SD, See WA, Lynch CF, Cantor KP: Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. Am J Epidemiol, 151: 377-383, 2000.
61. Zeegers MP, Dorant E, Goldbohm RA, van den Brandt PA: Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study. Cancer Causes Control, 12: 231-238, 2001.
62. Riboli E, Gonzales CA, Lopez-Abente G, Errezola M, Izarzugaza I, Escolar A, Nebot M, Hemon B, Agudo A: Diet and bladder cancer in Spain: a multi-centre case-control study. Int J Cancer, 49: 214-219, 1991.
63. Hebert JR, Miller DR: A Cross-national Investigation of diet and bladder cancer. Eur J Cancer, 30: 778-784, 1994.
64. Bruemmer B, White E, Vaughan TL, Cheney CL: Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol, 144: 485-495, 1996.
65. Radosavljević V, Janković S, Marinković J, Crossed D signokić M: Diet and bladder cancer: A case-control study. Int Urol Nephrol. 37: 283-289, 2005.
66. Steineck G, Hagman U, Gerhardsson M, Norell SE: Vitamin A supplements, fried foods, fat and urothelial cancer. A case-referent study in Stockholm in 1985-87. Int J Cancer, 45: 1006-1011, 1990.
67. Vena JE, Graham S, Freudenheim J, Marshall J, Ziclezny M, Swanson M, Sufrin G: Diet in the epidemiology of bladder cancer in western New York. Nutr Cancer, 18: 255-264, 1992.
68. Steineck 6, Norell SE, Feychting M: Diet, tobacco and urothelial cancer. Acta Oncologica, 27: 323-327, 1988.
69. Wilkens LR, Kadir MM, Kolonel LN, Nomura AM, Hankin JH: Risk factors for lower urinary tract cancer: the role of total fluid consumption, nitrites and nitrosoamines, and selected foods. Cancer Epidemiol Biomarkers Prev, 5: 161-166, 1996.
70. Balbi JC, Larrinaga MT, De Stefani E, Mandilaharsu M, Ronco AL, Boffetta P, Brennan P: Foods and risk of bladder cancer: a case-control study in Uruguay. Eur J Cancer Prev. 10: 453-458, 2001.
71. Radosavljević V, Janković S, Marinković J, Crossed D signokić M: Non-occupational risk factors for bladder cancer: A case-control study. Tumori, 90: 175-180, 2004.
72. Gan J, Skipper P, Gago-Dominguez M, Arakawa K, Ross RK, Yu CM, Tannenbaum RS: Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst, 96: 1425-1431, 2004.
73. Risch HA, Burch JD, Miller AB, Hill GB, Steele R, Howe GR: Dietary factors and the incidence of cancer of the urinary bladder. Am J Epidemiol, 127: 1179-1191, 1988.
74. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N, Kitamura T, Kawabe K, Kotake T, Kuroda M, Naito S, Koga H, Saito Y, Nomata K, Kitagawa M, Aso Y: Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int, 68: 273-280, 2002.
75. Aso Y, Akaza H, the BLP Study Group: Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int, 49: 125-129, 1992.
76. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S, the BLP Study Group: Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur Urol, 27: 104-109, 1995.
77. Michaud DS, Spiegelman D, Clinton SK, Rimm BE, Willett CW, Giovannucci E: Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US Men. Am J Epidemiol, 152: 1145-1153, 2000.
78. Schabath MB, Grossman HB, Delclos GL, Hernandez LM, Day RS, Davis BR, Lerner SP, Margaret RS, Xifeng W: Dietary carotenoids and genetic instability modify bladder cancer risk. J Nutr, 134: 3362-3369, 2004.
79. Sun CL, Yuan JM, Arakawa K, Low SH, Lee HP, Yu MC: Dietary soy and increased risk of bladder cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev, 11: 1674-1677, 2002.
80. Sun CL, Yuan JM, Wang X, Gao Y, Ross R, Yu MC: Dietary soy and increased risk of bladder cancer: a prospective cohort study of men in Shanghai, China. Int J Cancer, 112: 319-323, 2004.
81. Sasaki YF, Nishidate E, Izumiyama F, Watanabe-Akanuma M, Kinae N, Matsusaka N, Tsuda S: Detection of in vivo genotoxicity of 3-chloro-4- (dichloromethyl)-5-hydroxy-2[5H]-furanone (MX) by the alkaline single cell gell electrophoresis (Comet) assay in multiple mouse organs. Mutat Res, 393: 47-53, 1997.
82. International Agency for research on Cancer: Shistosomes, liver flukes and Helicobacter pylori. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol 61, IARC, Lyon 1994.
83. Hodder SL, Mahmoud AA, Sorenson K, Weinert DM, Stein RL, Ouma JH, Koech D, King CH: Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am J Trop Med Hyg, 63: 133-138, 2000.
84. Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF: Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil, 83: 346-351, 2002.
85. Hisataki T, Miyao N, Masumori N, Takahashi A, Sasai M, Yanase M, Itoh N, Tsukamoto T: Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology, 55: 663-667, 2000.
86. Sadetzki S, Bensal D, Blumstein T, Novikov I, Modan B: Selected risk factors for transitional cell bladder cancer. Med Oncol, 17: 179-182, 2000.
87. Singh A, Kinoshita Y, Rovito PM Jr, Landas S, Silberstein J, Nsouli I, Wang CY, Haas GP: Higher than expected association of clinical prostate and bladder cancers. J Urol, 173: 1526-1529, 2005.
88. Kravchick S, Gal R, Cytron S, Peled R, Weissman Y, Mukamel E, Koren R: Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder. Pathol Oncol Res, 7: 56-59, 2001.
89. Kaye JA, Jick H: Statin use and cancer risk in the General Practice Research Database. Br J Cancer, 90: 635-637, 2004.
90. Piper J, Tonascia J, Matanoski G: Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. N Engl J Med, 313: 292-295, 1985.
91. Knight A, Askling J, Granath F, Sparen P, Ekbom A: Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis, 63: 1307-1311, 2004.
92. Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK: Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer, 82: 1364-1369, 2000.
93. Hein DW: Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res, 506-507: 65-77, 2002.
94. Hein DW, Doll MA, Fretland JA, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y: Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev, 9: 29-42, 2000.
95. Gu J, Liang D, Wang Y, Lu C, Wu X: Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat Res, 581: 97-104, 2005.
96. Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK: Acetylator phenotype, aminobipheyl-hemoglobin adducts levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst, 86: 712-716, 1994.
97. Marcus PM, Vineis P, Rothman N: NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics, 10: 115-122, 2000.
98. Engel SE, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmöller J, Daly AK, Heckbert SR, Kalina I, Kang D, Katoh T, Lafuente A, Lin HJ, Romkes M, Taylor JA, Rothman N: Human genome epidemiology (HuGE) review. Am J Epidemiol, 156: 95-109, 2002.
99. Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT: Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett, 219: 63-69, 2005.
100. Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, Verbeek AL, Kiemeney LA: Familial aggregation of urothelial cell carcinoma. Int J Cancer, 98: 274-278, 2002.
101. Pina K, Hemminki K: Familial bladder cancer in the national Swedish Family Cancer Database. J Urol, 166: 2129-2133, 2001.